首页> 外文期刊>Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research >Review of the Task Force Report on PRO Data Collection in Clinical Trials Using Mixed Modes
【24h】

Review of the Task Force Report on PRO Data Collection in Clinical Trials Using Mixed Modes

机译:使用混合模式审查临床试验中PRO数据收集工作队报告

获取原文
获取原文并翻译 | 示例
           

摘要

Congratulations to the ISPOR PRO Mixed Modes Good Research Practices Task Force [1] for tackling a challenging question that many patient-reported outcome (PRO) researchers have pondered either publicly or privately as they review PRO results tables based on data collected through a combination of data collection methods: "Would these results and the study conclusions be different if the same mode had been employed?" The report's general recommendation to "Just say no!" to mixing modes within a single study (or set of studies that may be pooled) is good advice and, if followed, will save many headaches and resources. If ignored and data are combined without consideration of the guidance offered in this report, post hoc evaluations may be necessary to backfill evidence to support the fact that the PRO data and conclusions are not compromised, especially to support medical product labeling.
机译:恭喜ISPOR PRO混合模式优良研究实践工作组[1]解决了一个具有挑战性的问题,即许多患者报告的结局(PRO)研究人员在基于通过结合以下方式收集的数据审查PRO结果表时,已经公开或私下考虑过数据收集方法:“如果采用相同的模式,这些结果和研究结论是否会有所不同?”该报告的一般建议是“只说不!”在单个研究(或一组可能合并的研究)中混合模式是一个很好的建议,如果遵循的话,将节省很多麻烦和资源。如果忽略并且在不考虑本报告提供的指导的情况下合并数据,则可能需要事后评估,以回填证据以支持PRO数据和结论不受影响的事实,尤其是支持医疗产品标签。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号